Myovant Sciences Ltd. MYOV
26.98 +26.98
Day range unavailable
52-week range unavailable
News
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Nov. 11, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ("Myovant" or the "Company") (NASDAQ: MYOV).
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ("Myovant" or the "Company") (NASDAQ: MYOV).
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Oct. 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ("Myovant" or the "Company") (NASDAQ: MYOV).
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Oct. 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ("Myovant" or the "Company") (NASDAQ: MYOV).
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ("Myovant" or the "Company") (NASDAQ: MYOV).
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV NEW YORK , Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd.
zacks.com Myovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimates Myovant Sciences (MYOV) delivered earnings and revenue surprises of -5.36% and 3.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
prnewswire.com SHAREHOLDER ALERT: Weiss Law Reminds MYOV, KNBE, LMST, and PEBO Shareholders About Its Ongoing Investigations NEW YORK , Nov. 1, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
zacks.com Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates Myovant Sciences (MYOV) delivered earnings and revenue surprises of 4.08% and 13.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
benzinga.com Earnings Scheduled For October 26, 2022 Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022 Upgrades
benzinga.com Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
benzinga.com Avis Budget, Scholastic And Other Big Gainers From Monday U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.
pulse2.com Why Sumitomo Pharma Is Buying Myovant Sciences (MYOV) For $2.9 Billion Sumitovant Biopharma recently announced it is buying Myovant Sciences (MYOV) in a $2.9 billion deal. This is why.
globenewswire.com Myovant Sciences Cancels Second Quarter Earnings Conference Call BASEL, Switzerland, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of its earnings conference call for the quarter ended September 30,…- benzinga.com Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,…
investorplace.com MYOV Stock Pops as Sumitomo Agrees to Buy Myovant Sciences Today's market-moving news in the drugmaker sector is that Sumitomo Pharma and a subsidiary have agreed to buy out the remainder of Myovant Sciences (NYSE: MYOV ) that they don't already own.…
benzinga.com Why Myovant Sciences Stock Is Moving Higher - Myovant Sciences (NYSE:MYOV) Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher Monday after the company announced it will be acquired by Sumitovant Biopharma for $27 per share in cash.
marketwatch.com Myovant Sciences shares trading higher after agreeing to Sumitomo deal for $2.9 billion Shares of Myovant Sciences Ltd. MYOV, +0.95% were up 8.2% in premarket trading on Monday, the day after the company said it will be acquired by Sumitomo Pharma Co. Ltd.
benzinga.com Myovant Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.- benzinga.com Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
globenewswire.com Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. BASEL, Switzerland, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), today announced it will host a webcast and conference call to discuss corporate updates and financial results for…
seekingalpha.com Myovant Sciences: What The Sumitomo Offer Foretells As Myovant overcame the odds as I forecast, Myfembree garnered another FDA approval to treat endometriosis. Subsequent to the said game-changing event, Sumitomo made an offer to acquire all…
seekingalpha.com Myovant: Sumitomo Bid Is A Head Scratcher, Where Is The Value? Myovant stock has rocketed in value by >100% since my last (bearish) note on the company. The main reason for the Myovant gains is an attempt by majority shareholder Sumitomo to acquire remaining…
benzinga.com Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per…- benzinga.com Nasdaq Jumps 270 Points; Silver Surges Over 8% U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.
- benzinga.com Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
- benzinga.com S&P 500 Surges 2%; Crude Oil Rises Sharply U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.
fool.com Why Myovant Sciences Stock Is Skyrocketing Today Myovant said "no thanks" to an acquisition offer in hopes to fetch a higher price.
invezz.com Myovant stock opened 35% up on Monday: here's the catalyst Myovant Sciences Ltd (NYSE: MYOV) opened nearly 35% up on Monday after the biopharmaceutical company said it rejected a buyout proposal from its largest shareholder. Myovant is open to considering a…
schaeffersresearch.com Myovant Sciences Stock Skyrockets After Rejecting Buyout Offer Myovant Sciences Ltd (NYSE:MYOV) stock is soaring today, up 35.7% at $24.48 at last glance, after the biopharmaceutical name rejected a buyout offer from Japan-based Sumitomo Pharma.- benzinga.com Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers
- benzinga.com Earnings Scheduled For July 27, 2022 Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
benzinga.com Earnings Scheduled For May 10, 2022 Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 431 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 236 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 729 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For January 26, 2022 Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For October 26, 2021 Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
- benzinga.com Earnings Scheduled For July 28, 2021 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion.
benzinga.com Earnings Scheduled For May 11, 2021 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.- benzinga.com Earnings Scheduled For February 11, 2021 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.55 per share on revenue of $54.86 million.
- benzinga.com 84 Biggest Movers From Yesterday Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE accepted its plan for continued listing.
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 58 Stocks Moving In Monday's Mid-Day Session Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for continued listing.
- benzinga.com Stocks That Hit 52-Week Highs On Monday This morning 301 companies reached new 52-week highs.